Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Pott, Christiane
[Clear All Filters]
Journal Article
Fischer L
,
Jiang L
,
Dürig J
,
Schmidt C
,
Stilgenbauer S
,
Bouabdallah K
,
Solal-Celigny P
,
Scholz CW
,
Feugier P
,
de Wit M
, et al.
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Leukemia. 2024.
PubMed
Google Scholar
Alig S
,
Jurinovic V
,
Esfahani MShahrokh
,
Haebe S
,
Passerini V
,
Hellmuth JC
,
Gaitzsch E
,
Keay W
,
Tahiri N
,
Zoellner A
, et al.
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
Blood Adv. 2020;4(18):4451-4462.
PubMed
Google Scholar
Hermine O
,
Jiang L
,
Walewski J
,
Bosly A
,
Thieblemont C
,
Szymczyk M
,
Pott C
,
Salles G
,
Feugier P
,
Hübel K
, et al.
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
J Clin Oncol. 2022:JCO2201780.
PubMed
Google Scholar
Dreyling M
,
Doorduijn J
,
Giné E
,
Jerkeman M
,
Walewski J
,
Hutchings M
,
Mey U
,
Riise J
,
Trneny M
,
Vergote V
, et al.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomis
. Lancet. 2024.
PubMed
Google Scholar
Metzner B
,
Müller TH
,
Casper J
,
Kimmich C
,
Köhne C-H
,
Petershofen E
,
Renzelmann A
,
Thole R
,
Voss A
,
Dreyling M
, et al.
Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Eur J Haematol. 2023.
PubMed
Google Scholar